Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amicus Therapeutics (FOLD) Non Operating Investment Income (2018)

Historic Non Operating Investment Income for Amicus Therapeutics (FOLD) over the last 1 years, with Q2 2018 value amounting to -$7.6 million.

  • Amicus Therapeutics' Non Operating Investment Income changed N/A to -$7.6 million in Q2 2018 from the same period last year, while for Jun 2019 it was -$7.6 million, marking a year-over-year change of. This contributed to the annual value of -$2.7 million for FY2018, which is N/A changed from last year.
  • Per Amicus Therapeutics' latest filing, its Non Operating Investment Income stood at -$7.6 million for Q2 2018.
  • Amicus Therapeutics' Non Operating Investment Income's 5-year high stood at $4.9 million during Q1 2018, with a 5-year trough of -$7.6 million in Q2 2018.